scholarly journals Long-term outcomes of peroral endoscopic myotomy in achalasia patients with a minimum follow-up of 7 years

2020 ◽  
Vol 133 (8) ◽  
pp. 996-998
Author(s):  
Wen-Gang Zhang ◽  
Ning-Li Chai ◽  
Ya-Qi Zhai ◽  
En-Qiang Linghu ◽  
Hui-Kai Li
2016 ◽  
Vol 83 (5) ◽  
pp. AB628 ◽  
Author(s):  
Saowanee Ngamruengphong ◽  
Haruhiro Inoue ◽  
Amol Bapaye ◽  
Michael Ujiki ◽  
Lava Y. Patel ◽  
...  

2017 ◽  
Vol 85 (5) ◽  
pp. AB581
Author(s):  
Stavros N. Stavropoulos ◽  
Xiaocen Zhang ◽  
Rani J. Modayil ◽  
Krishna C. Gurram ◽  
Collin E. Brathwaite ◽  
...  

Endoscopy ◽  
2020 ◽  
Author(s):  
Olivier Ragi ◽  
Jérémie Jacques ◽  
Julien Branche ◽  
Sarah Leblanc ◽  
Geoffroy Vanbiervliet ◽  
...  

Abstract Background: Data on the long-term outcomes of gastric peroral endoscopic myotomy (G-POEM) for refractory gastroparesis are lacking. We report the results of a large multicenter long-term follow-up study of G-POEM for refractory gastroparesis. Methods: This was a retrospective multicenter study of all G-POEM operations performed in seven expert French centers for refractory gastroparesis with at least 1 year of follow-up. The primary endpoint was the 1-year clinical success rate, defined as at least a 1-point improvement in the Gastroparesis Cardinal Symptom Index (GCSI). Results: 76 patients were included (60.5 % women; age 56 years). The median symptom duration was 48 months. The median gastric retention at 4 hours (H4) before G-POEM was 45 % (interquartile range [IQR] 29 % – 67 %). The median GCSI before G-POEM was 3.6 (IQR 2.8 – 4.0). Clinical success was achieved in 65.8 % of the patients at 1 year, with a median rate of reduction in the GCSI score of 41 %. In logistic regression analysis, only a high preoperative GCSI satiety subscale score was predictive of clinical success (odds ratio [OR] 3.41, 95 % confidence interval [CI] 1.01 – 11.54; P = 0.048), while a high rate of gastric retention at H4 was significantly associated with clinical failure (OR 0.97, 95 %CI 0.95 – 1.00; P = 0.03). Conclusions: The results confirm the efficacy of G-POEM for the treatment of refractory gastroparesis, as evidenced by a 65.8 % clinical success rate at 1 year. Although G-POEM is promising, prospective sham-controlled trials are urgently needed to confirm its efficacy and identify the patient populations who will benefit most from this procedure.


2018 ◽  
Vol 64 (3) ◽  
pp. 803-810 ◽  
Author(s):  
Chenghai He ◽  
Meng Li ◽  
Bin Lu ◽  
Xiao Ying ◽  
Chen Gao ◽  
...  

Esophagus ◽  
2019 ◽  
Vol 17 (1) ◽  
pp. 3-10 ◽  
Author(s):  
Haruhiro Inoue ◽  
Hironari Shiwaku ◽  
Yasutoshi Kobayashi ◽  
Philip W. Y. Chiu ◽  
Robert H. Hawes ◽  
...  

Abstract It has been 10 years since peroral endoscopic myotomy (POEM) was reported for the first time, and POEM has currently become the standard treatment for achalasia and related disorders globally because it is less invasive and has a higher curative effect than conventional therapeutic methods. However, there are limited studies comparing the long-term outcomes of POEM with those of conventional therapeutic methods, particularly in the occurrence of gastroesophageal reflux disease (GERD) after therapy. With this background, we held a consensus meeting to discuss the pathophysiology and management of GERD after POEM based on published papers and experiences of each expert and to discuss the prevention of GERD and dealing with anti-acid drug refractory GERD. This meeting was held on April 27, 2018 in Tokyo to establish statements and finalize the recommendations using the modified Delphi method. This manuscript presents eight statements regarding GERD after POEM.


2020 ◽  
Vol 08 (05) ◽  
pp. E650-E655 ◽  
Author(s):  
Olaya I. Brewer Gutierrez ◽  
Robert A. Moran ◽  
Pietro Familiari ◽  
Mohamad H. Dbouk ◽  
Guido Costamagna ◽  
...  

Abstract Background and study aims Per-oral endoscopic myotomy (POEM) is associated with a short-term clinical response of 82 % to 100 % in treatment of patients with achalasia. Data are limited on the long-term durability of the clinical response in these patients. The aim of this study was to determine the long-term outcomes of patients undergoing POEM for management of achalasia. Methods This was a retrospective multicenter cohort study of consecutive patients who underwent POEM for management of achalasia. Patients had a minimum of 4 years follow-up. Clinical response was defined by an Eckardt score ≤ 3. Results A total of 146 patients were included from 11 academic medical centers. Mean (± SD) age was 49.8 (± 16) years and 79 (54 %) were female. The most common type of achalasia was type II, seen in 70 (47.9 %) patients, followed by type I seen in 41 (28.1 %) patients. Prior treatments included: pneumatic dilation in 29 (19.9 %), botulinum toxin injection in 13 (8.9 %) and Heller myotomy in seven patients (4.8 %). Eight adverse events occurred (6 mucosotomies, 2 pneumothorax) in eight patients (5.5 %). Median follow-up duration was 55 months (IQR 49.9–60.6). Clinical response was observed in 139 (95.2 %) patients at follow-up of ≥ 48 months. Symptomatic reflux after POEM was seen in 45 (32.1 %) patients, while 35.3 % of patients were using daily PPI at 48 months post POEM. Reflux esophagitis was noted in 16.8 % of patients who underwent endoscopy. Conclusion POEM is a durable and safe procedure with an acceptably low adverse event rate and an excellent long-term clinical response.


Sign in / Sign up

Export Citation Format

Share Document